Catalyst Wire Dossier Catalyst Wire Dossier

autologous alveolar bone-marrow derived mesenchymal stem cells

mesenchymal stem cells
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for autologous alveolar bone-marrow derived mesenchymal stem cells, covering 2018-11-01 to 2018-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Dental Implant Placement in Adjunction With Autologous Alveolar Bone-Marrow Derived Mesenchymal Stem Cells (aBM-MSCs) [Phase 1, Phase 2]

See pricing